Skip to content

A study to evaluate the efficacy of Bharangyadi Madhuka and Talishadi Churna in the management of Tamaka Shwas(Bronchial Asthma)

An Open Labelled Comparative Clinical Study to Evaluate the Efficacy of Bharangyadi Madhuka and Talishadi Churna in the Management of Tamaka Shwas with special Reference to Bronchial Asthma - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071146
Enrollment
60
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

None listed

Sponsors

Institute For Ayurved Studies and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient willing for clinical trial and ready to give written Consent. 2 Patient between the age group of 25-60 years of either sex. 3 Patients fulfill the diagnostic criteria of Tamaka Shwasa (Bronchial Asthma). 4 Patients presented with cardinal features of Tamaka Shwasa as described in Ayurveda texts. 5 Diagnosed and confirmed cases of Tamaka Shawasa (Bronchial Asthma) on the basis of criteria given by NAEPP having Mild Intermittent and Mild Persistent type of Asthma

Exclusion criteria

Exclusion criteria: 1 Patient not willing to Clinical Trial 2 Patients not fulfilling the Inclusion Criteria. 3 Patient having an Age below 25 and Above 60. 4 Patients having a medical history of CHF, CAD, Pulmonary hypertension, Diabetes Mellitus, Uncontrolled hypertension, CKD, and Autoimmune disorders. 5 During Pregnancy, Lactation period 6 Patients on Steroid therapy, Inhaler. 7 Patient Suffering from Secondary Respiratory Disease

Design outcomes

Primary

MeasureTime frame
Decrease in the sign and symptoms such as Frequency, episodes and intensity of attack, cough with sputum, chest pain, irritation in throat, rhinitis, thirst.Timepoint: 21 days

Secondary

MeasureTime frame
Improvement in the levels of chest X ray, AEC, CRP, PFT. Reduction in scoring pattern of assessment criteria. Timepoint: 42 days

Countries

India

Contacts

Public ContactDr Adbhut Kumar Mundhara

Institute For Ayurved Studies and Research

mehranilam@gmail.com9671368058

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026